Trackwise (b)(4) updated section: b4, e3, g4, g7, h2, h3, h6, h10, h11 corrected section: d4- udi#- corrected to unk the device was returned to the factory on 08/11/2021.An engineer evaluation was conducted on 09/15/2023 with the following results, see attached engineer evaluation: "the device, vs01503087b0 ¿ fusion bioline 7mm-80cm supp peripheral graft, was visually evaluated by the subject matter experts (smes), which includes a production supervisor and a manufacturing engineer.The evaluation determined that there was no material separation observed along the length of the graft.However, material separation was observed on the right side of the graft, specifically in areas where the graft had been cut at an oblique angle (see figure 1) and where the external support coil had been removed (see figure 2) by the end user.Therefore, the reported failure - material separation in complaint one track (b)(4) was confirmed.The lot # 25154077 history record review was completed.There was ncmrs , rework or deviations documented for the reported lot number.Based on the dhr/lhr review results, it was determined that there is no relation between the batch manufacturing process and the reported failure.
|